Mitral Valve Repair for Active and Healed Endocarditis.
- Author:
Man Jong BAEK
1
;
Chan Young NA
;
Sam Sae OH
;
Woong Han KIM
;
Sung Wook WHANG
;
Cheol LEE
;
Chang Hyun KANG
;
Yunhee CHANG
;
Won Min JO
;
Jae Hyun KIM
;
Hong Ju SEO
;
Wook Sung KIM
;
Young Tak LEE
;
Chong Whan KIM
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital, Sejong Heart Institute, Bucheon, Korea. kubmj@chollian.net
- Publication Type:Original Article
- Keywords:
Endocarditis;
Mitral valve regurgitation;
Mitral valve, repair
- MeSH:
Cardiopulmonary Bypass;
Echocardiography;
Embolism;
Endocarditis*;
Follow-Up Studies;
Freedom;
Humans;
Male;
Mitral Valve Annuloplasty;
Mitral Valve Insufficiency;
Mitral Valve Stenosis;
Mitral Valve*;
Reoperation;
Retrospective Studies;
Weaning
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2003;36(11):820-827
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Mitral valve repair rather than replacement for mitral regurgitation (MR) offers a number of well-accepted benefits. However, the surgical results of repair for mitral valve endocarditis remain largely unknown. MATERIAL AND METHOD: Fourteen patients who underwent mitral valve repair for MR caused by mitral valve endocarditis from April 1995 through October 2001 were reviewed retrospectively. There were 9 male patients and mean age was 32+/-10 years. Four patients had previous embolism and 2 had active infections. The grade of MR were III in 6 patients and IV in 8. Operatively, mitral annuloplasty was performed in 12 patients and various valvuloplasty techniques were applied in all patients. One patient had immediate valve replacement due to residual MR after weaning of cardiopulmonary bypass. RESULT: There was no early operative death. Early postoperative transthoracic echocardiography revealed no or grade I of MR and no or mild mitral stenosis in 13 patients. After the mean follow-up of 36 months, there was no late death, and no or grade I of MR in 11 patients (84.6%) and no or mild mitral stenosis in 12 patients (92.3%). Reoperation required in one patient (7.1%). The cumulative freedom from recurrent MR and valve-related reoperation at 5 years were 91+/-9% and 75+/-22%, respectively. CONCLUSION: This study suggests that mitral valve repair for mitral regurgitation caused by endocarditis offers good early and intermediate survival and functional improvement without reinfection, and it is an attractive alternative to valve replacement in selective patients with bacterial endocariditis.